ReviewISRN radiology2013
Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies.
Review in ISRN radiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.Journal of the American Heart Association · 2017Trial
- Targeted temperature management at 33 and 36 °C mitigates contrast-induced acute kidney injury.Scientific reports · 2026Article
- Trimetazidine effect on kidney function in patients undergoing coronary procedures.BMC pharmacology & toxicology · 2025Observational
- Outcomes and risk management in type B aortic dissection patients with acute kidney injury: a concise review.Renal failure · 2021Review
- Acute kidney injury following endovascular intervention for peripheral artery disease.The British journal of surgery · 2021Article
- Bioimpedance Analysis-Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial).Kidney international reports · 2020Article
- Histological and SEM Assessment of Blood Stasis in Kidney Blood Vessels after Repeated Intra-Arterial Application of Radiographic Contrast Media.Life (Basel, Switzerland) · 2020Article
- Carbon monoxide: An emerging therapy for acute kidney injury.Medicinal research reviews · 2020Review
- Anti-Apoptotic and Antioxidant Effects of 3-Biomolecules · 2020Article
- Protective Effects of Amlodipine Pretreatment on Contrast-Induced Acute Kidney Injury And Overall Survival In Hypertensive Patients.Frontiers in pharmacology · 2020Article
- Effect of astaxanthin on apoptosis of rat renal tubular epithelial cells induced by iohexol.American journal of translational research · 2019Article
- Protective Effect ofInternational journal of molecular sciences · 2018Article
- AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.Kidney international · 2017Review
- A new update for radiocontrast-induced nephropathy aggravated with glycerol in rats: the protective potential of epigallocatechin-3-gallate.Renal failure · 2017Article
- StatSensor-i point-of-care creatinine analyzer may identify patients at high-risk of contrast-induced nephropathy.Experimental and therapeutic medicine · 2017Article
- Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.European radiology · 2016Review
- Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children.Central-European journal of immunology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-induced acute kidney injury (CI-AKI) is one of the most widely discussed and debated topics in cardiovascular medicine. With increasing number of contrast-media- (CM-) enhanced imaging studies being performed and growing octogenarian population with significant comorbidities, incidence of CI-AKI remains high. In this review, pathophysiology of CI-AKI, its relationship with different types of CM, role of serum and urinary biomarkers for diagnosing CI-AKI, and various prophylactic strategies used for nephroprotection against CI-AKI are discussed in detail.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.